证券代码：300300 证券简称：汉鼎宇佑 汉鼎宇佑互联网股份有限公司投资者关系活动记录表 编号：2019-002 1 | --- | --- | |-----------------------|-------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 \n活动类别 | 特定对象调研 | | 参与单位名称及 | | | 人员姓名 | 湘财证券 李兵 中泰证券 杨汝才 黄刚 浙商创投 李猛 | | 时间 | 2019 年 05 月 17 日 | | 地点 | 浙江省杭州市永福桥路 5 号汉鼎国际大厦 15 层会议室 | | 上市公司接待 | 董事长 项坚；董事、副总经理、好医友董事长 Henry L.Huang ；董 | | 人员姓名 | 事、财务总监、董事会秘书 周为利 | | 投资者关系活动 | 问题 1 ：公司 2018 年可供出售金融资产增长较快，主要原因是哪 些？ | | 主要内容介绍 ...

证券代码：300300 证券简称：汉鼎宇佑 汉鼎宇佑互联网股份有限公司投资者关系活动记录表 编号：2018-001 1 | --- | --- | |-----------------------|-------------------------------------------------------------------------------| | 投资者关系 \n活动类别 | 特定对象调研 | | 参与单位名称及 | 浙银资本 胡凯旋；浙江洋哲晨资产 付俊荣； | | 人员姓名 | 北京久银投资 唐斌；证券时报 徐然。 | | 时间 | 2018 年 05 月 16 日下午 | | 地点 | 浙江省杭州市永福桥路 5 号汉鼎国际大厦 15 层会议室 | | 上市公司接待 | 董事长 项坚；副总经理 Henry L.Huang ；财务总监、董事会秘书 周 | | 人员姓名 | 为利；好医友总经理 颜伟煌。 | | 投资者关系活动 | 董事长项坚先生：感谢各位投资者参与本次活动，大家有关心的 问题，可以自由提问。 | | 主要内容介绍 | 1. 请问贵公司的主营业务主要是哪一板块？商业发展是影院建设 ...

证券代码：300300 证券简称：汉鼎宇佑 汉鼎宇佑互联网股份有限公司投资者关系活动记录表 编号：2019-001 | --- | --- | |---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300300 证券简称：海峡创新 编号：2021-002 | --- | --- | --- | |----------------|------------------------------|----------------------------------------------------------| | | ☑ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | 参与单位名称及 | 华金证券 魏赟 | | | 人员姓名 | | | | 时间 | 2021 年 9 月 30 日 | | | 地点 | 浙江省杭州市西湖区天目山路 | 181 号天际大厦 6 层 | | 上市公司接待人 | 副总经理、董事会秘书叶兴波 | 证券事务代表林楠芳 | | 员姓名 | | | | | 问题 1 | ：公司经营情况如何？主营业务市场前景大吗？ | | | 2021 | 年，公司继续聚焦"智慧城市+智慧医疗"两大主业， | | 投资 ...

证券代码：300300 证券简称：海峡创新 编号：2021-003 | --- | --- | --- | |----------------|--------------------------------|----------------------------------------------------------| | | ☑ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | 参与单位名称及 | 华创证券 孟灿 | | | 人员姓名 | | | | 时间 | 2021 年 11 月 26 | 日下午 | | 地点 | 浙江省杭州市西湖区天目山路 | 181 号天际大厦 6 层 | | 上市公司接待人 | | | | 员姓名 | 副总经理、董事会秘书叶兴波先生 | 证券事务专员左文娟女士 | | | 问题 | 1：公司经营情况发展现状以及主营业务市场前景？ | | | 2021 | 年，公司继续聚焦"智慧城市+智慧医疗"两大主 ...

证券代码：300300 证券简称：海峡创新 海峡创新互联网股份有限公司 投资者关系活动记录表 编号：2022-002 | --- | --- | --- | |----------------|--------------------------------|----------------------------| | | ☑ 特定对象调研 □分析师会议 | | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | 参与单位名称及 | | | | 人员姓名 | 天风证券 王奕红 | | | 时间 | 2022 年 2 月 24 日晚 | | | 地点 | 浙江省杭州市西湖区天目山路 | 181 号天际大厦 6 层 | | 上市公司接待人 | | | | 员姓名 | | | | | 副总经理、董事会秘书叶兴波先生 | 证券事务专员毛佳璋女士 | | --- | --- | |-----------------------------|--------------------- ...

证券代码：300300 证券简称：海峡创新 编号：2022-001 | --- | --- | --- | |-----------------------|----------------------------------|----------------------------------------------------------| | | ☑ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | 参与单位名称及 | 民生证券 于一铭 | | | 人员姓名 | | | | 时间 | 2022 年 1 月 14 日下午 | | | 地点 | 浙江省杭州市西湖区天目山路 | 181 号天际大厦 6 层 | | 上市公司接待人 员姓名 | 副总经理、董事会秘书叶兴波先生 | 证券事务专员左文娟女士 | | | 问题 | 1：公司智慧城市业务的范围以及市场前景如何？ | | | 2021 | 年，公司聚焦"智慧城市 + 智慧医疗"两大主 ...

重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 海峡创新互联网股份有限公司 2022 年第三季度报告 证券代码：300300 证券简称：海峡创新 公告编号：2022-062 海峡创新互联网股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 3.第三季度报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 53,254,361.33 | 8.12% | 118,944,880.79 | -67.13% | | ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥65,690,519.46, a decrease of 78.99% compared to ¥312,663,138.13 in the same period last year[25]. - The net profit attributable to shareholders was a loss of ¥60,823,830.64, representing a decline of 284.03% from a profit of ¥33,050,938.98 in the previous year[25]. - The basic earnings per share were -¥0.0906, a decline of 284.15% compared to ¥0.0492 in the same period last year[25]. - The weighted average return on net assets was -11.84%, a decrease of 15.41 percentage points from 3.57% in the previous year[25]. - The company reported a net loss for the first half of 2022 of ¥61,391,108.71, compared to a net profit of ¥32,027,734.22 in the same period of 2021[147]. - The total operating revenue for the first half of 2022 was CNY 65,690,519.46, a decrease of 78.97% compared to CNY 312,663,138.13 in the same period of 2021[146]. - The net profit for the first half of 2022 was -59,825,886.35, compared to a net profit of 44,653,705.68 in the same period of 2021, indicating a significant decline[151]. Cash Flow and Liquidity - The net cash flow from operating activities improved to ¥3,682,449.90, a significant increase of 103.94% compared to a negative cash flow of ¥93,519,687.00 in the same period last year[25]. - Cash and cash equivalents decreased from CNY 58,168,767.68 to CNY 36,597,765.87, a decrease of approximately 37%[139]. - The net cash flow from financing activities was -11,979,175.45 CNY, an improvement from -51,589,563.53 CNY in the previous period, indicating a reduction in cash outflow[157]. - The total cash inflow from financing activities was 427,200,000.00 CNY, which is a significant source of liquidity for the company[157]. - The company maintained a cash reserve of 12,398,113.78 CNY, which is critical for future investments and operational stability[157]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,407,947,494.64, down 11.81% from ¥1,596,437,036.74 at the end of the previous year[25]. - Total liabilities decreased from CNY 1,053,957,002.34 to CNY 923,662,838.81, a decline of about 12.3%[141]. - The company's total assets decreased to CNY 2,493,018,826.00 in the first half of 2022 from CNY 2,542,533,931.63 in the same period of 2021[145]. - The total equity of the company decreased to CNY 1,299,934,355.25 in the first half of 2022 from CNY 1,359,435,729.10 in the same period of 2021[145]. Research and Development - The company maintained R&D investment at ¥6,569,691.36, a slight decrease of 1.89% from ¥6,696,483.59[51]. - Research and development expenses for the first half of 2022 were CNY 6,569,691.36, slightly down from CNY 6,696,483.59 in the first half of 2021[147]. - The company has a total of 12 invention patents, 37 utility model patents, and 301 software copyrights, reflecting its commitment to technology research and development[46]. Strategic Focus and Business Development - The company has been focusing on the smart city sector for 20 years, participating in over a thousand smart engineering projects, and holds "11 Class A" qualifications[35]. - The company is actively developing its smart healthcare business, leveraging internet hospitals and international cooperation to enhance its service offerings[36]. - The company is strategically expanding its business in key areas such as IDC, resilient cities, and smart transportation, while also optimizing its business structure[40]. - The company plans to leverage its unique geographical advantages in Pingtan to enhance cross-strait medical cooperation and develop health industries[36]. - The company aims to enhance its market competitiveness in the smart industry through strategic partnerships and collaboration with leading enterprises[40]. Shareholder and Governance - The company did not distribute cash dividends or bonus shares for the first half of 2022[87]. - The company held its first temporary shareholders' meeting on January 26, 2022, with an investor participation rate of 16.21%[85]. - The second temporary shareholders' meeting was held on April 18, 2022, with a participation rate of 16.20%[85]. - The company has not reported any significant changes in shareholding structure or major shareholder activities during the period[124]. Legal and Compliance - The company reported a total of 4,338.71 million yuan in external guarantees related to litigation as of February 2022[101]. - There were no major litigation or arbitration matters reported during the period[100]. - The company has not engaged in any significant related party transactions during the reporting period[102]. Risk Management - The company is enhancing its investment management processes to mitigate risks associated with its diverse investment portfolio[78]. - Accounts receivable management is a priority, as increasing aging receivables could impact cash flow and operational efficiency[79]. - The company recognizes the importance of talent retention and is implementing strategies to enhance its appeal to high-quality personnel[80]. Environmental and Social Responsibility - The company aims to integrate social responsibility into shareholder and employee rights protection, as well as environmental protection[92]. - The company reported no significant environmental penalties during the reporting period[91]. Financial Reporting and Audit - The company’s half-year financial report has not been audited[98]. - The financial report was approved by the board of directors on August 25, 2022, ensuring compliance with accounting standards[172].

Financial Performance - The company's operating revenue for 2021 was approximately ¥474.08 million, representing a 34.07% increase compared to ¥353.60 million in 2020[24]. - The net profit attributable to shareholders for 2021 was a loss of approximately ¥363.38 million, an improvement of 38.28% from a loss of ¥588.79 million in 2020[24]. - The net cash flow from operating activities was a negative ¥103.40 million, a decline of 316.49% compared to a negative ¥24.83 million in 2020[24]. - The total assets at the end of 2021 were approximately ¥1.60 billion, a decrease of 13.49% from ¥1.85 billion at the end of 2020[24]. - The net assets attributable to shareholders decreased by 40.36% to approximately ¥542.38 million from ¥909.41 million in 2020[24]. - The basic earnings per share for 2021 was -¥0.54, improving by 37.93% from -¥0.87 in 2020[24]. - The company reported a weighted average return on equity of -50.05% for 2021, slightly worsening from -48.39% in 2020[24]. - The total non-recurring losses for 2021 amounted to CNY -128,791,696.06, reflecting significant financial challenges during the year[30]. - The company achieved a total revenue of 474.08 million yuan in 2021, representing a year-on-year increase of 34.07%[46]. - Revenue from the smart city and finance segment was 413.98 million yuan, accounting for 87.32% of total revenue, with a year-on-year growth of 39.71%[55]. - The smart healthcare and commercial segment generated 60.10 million yuan, making up 12.68% of total revenue, with a year-on-year increase of 4.91%[55]. - The company reported a change in the scope of consolidation during the reporting period[62]. - The company reported a total distributable profit of -1,159,916,052.21 yuan, with no cash dividends proposed for the year[169]. Strategic Focus and Development - The company plans to focus on strategic optimization in smart city and smart healthcare sectors[6]. - The company aims to develop its smart healthcare sector, with its subsidiary obtaining an internet hospital practice license and plans to establish a "Sino-foreign remote medical alliance"[38]. - The company has been focusing on the smart city sector for 20 years, participating in over a thousand projects, which positions it as a leading service provider in this field[37]. - The company is actively participating in the construction of 5G infrastructure and other strategic projects in the Pingtan Comprehensive Experimental Zone, aiming to support the development of a digital economy integration demonstration area[49]. - The company plans to optimize existing asset segments while ensuring steady growth in its main business areas[96]. - Internet healthcare is identified as a strategic industry for future development, driven by the ongoing demand for digital healthcare solutions[95]. - The company aims to enhance its market competitiveness in smart industries through ongoing R&D projects and strategic initiatives[69]. - The company is focusing on technology research and innovation in areas such as smart cities, resilient cities, and smart transportation, collaborating with universities and national research institutes[48]. Research and Development - The company has accumulated 12 invention patents, 37 utility model patents, and 280 software copyrights, emphasizing its commitment to technology research and development[42]. - The company is developing a conceptual smart device called "smart box" aimed at enhancing urban resilience and data collection capabilities[69]. - R&D expenses increased by 4.16% to ¥27,067,604.27, accounting for 5.71% of total revenue[70]. - The number of R&D personnel decreased by 3.23% to 90, with a notable decline in those with lower educational qualifications[70]. - The company plans to strengthen its R&D capabilities in AI, big data, and cloud computing to drive innovation in smart city solutions[102]. Risk Management - The company acknowledges the presence of risks in its future operations but does not foresee any major risks affecting its normal operations[6]. - The company aims to strengthen risk control and project management capabilities to enhance overall value and competitiveness[96]. - The company is committed to risk management by improving internal audit resources and establishing a comprehensive risk management system[103]. - The company faces external market competition risks, particularly in the post-pandemic environment, which may impact business operations[106]. - The company is aware of investment risks due to the diverse nature of its projects and will enhance investment management processes[109]. - The company will strengthen accounts receivable management to mitigate risks associated with long aging receivables[110]. - The company faces risks of talent competition and turnover due to business structure changes and industry competition, emphasizing the importance of attracting and retaining high-quality talent[111]. Corporate Governance - The company held three shareholder meetings during the reporting period, ensuring compliance with regulations and protecting minority shareholders' rights[116]. - The board of directors consists of 9 members, including 3 independent directors, meeting legal requirements and enhancing decision-making efficiency[117]. - The supervisory board held 5 meetings, ensuring oversight of major transactions and compliance with legal obligations[119]. - The company maintains independence from its controlling shareholder, ensuring autonomous operations in business and financial matters[120]. - The company adheres to strict information disclosure practices, ensuring transparency and timely communication with investors[121]. - The company has established an independent audit committee to oversee internal and external audits, ensuring compliance with financial regulations[126]. - The company has a structured decision-making process for determining the remuneration of its directors and senior management[150]. - The company has not faced any penalties from securities regulatory authorities for its directors and senior management in the past three years[147]. Employee and Management - The total number of employees at the end of the reporting period is 410, with 207 in the parent company and 203 in major subsidiaries[163]. - Employee compensation accounts for 9.85% of the total costs, with the portion included in cost accounting being 1.92%[165]. - The company has implemented a training program as part of its long-term strategy to enhance employee skills and meet organizational goals[166]. - The company has no stock incentive plans or employee stock ownership plans in place during the reporting period[170]. - The current management team includes experienced professionals with backgrounds in finance, banking, and technology, enhancing the company's strategic capabilities[135]. Future Outlook - The strategic focus for 2022 includes enhancing smart city projects and internet healthcare services, which are expected to drive future growth[96]. - The company provided a positive outlook for the next quarter, projecting a revenue increase of 20% to 1.8 billion RMB[143]. - Future performance guidance indicates a stable outlook with potential for incremental growth in user base and revenue[138]. - The management emphasized the importance of enhancing user experience through innovative solutions, aiming for a 30% improvement in customer satisfaction metrics[143]. - Future strategies will focus on sustainability initiatives, with a commitment to reduce carbon emissions by 20% over the next three years[143]. Subsidiaries and Investments - The company has established several subsidiaries, including Hakim Unique Technology Limited and Baotai (Fujian) Information Technology Co., Ltd., to enhance its operational capabilities[90]. - The company acquired 51% control of Fujian Haixia Wanying Smart Hospital Management Co., Ltd. and included it in the consolidated financial statements[195]. - The company increased its ownership in Zhejiang Haixia Innovation Technology Co., Ltd. from 55% to 100% during the reporting period[196]. - The company is involved in a lawsuit with Qiaoxing, with a claim amount of 6,309.98 million, which has been recognized as a contingent liability[199]. Environmental and Social Responsibility - The company has not faced any administrative penalties related to environmental issues during the reporting period[179]. - The company is not classified as a key pollutant discharge unit by environmental protection authorities[179]. - The company has committed to creating value for customers, employees, and society while maintaining a leading level in core technologies[180]. - No precise poverty alleviation work has been conducted in the reporting year, and there are no subsequent plans for such initiatives[181].